BIO

Bio-Rad Laboratories Inc

369.14

Oct 02 • 3:59 PM ET 0.00 (0.00%)

Healthcare Medical Devices USA Mid NYSE

Oct 01, 12:02 PMHot ISM input-cost reading lifts Treasury yields, pushing Bio-Rad down 4% by midday

Peers: BRKR QGEN A RGEN MTD WAT TECH TMO DHR IDXX

| Held by: IJH VTI VB DFSV VBR VXF MDY SPMD FEGE IWR

Scroll to Statements

Index	-
Market Cap	9.92B
Enterprise Value	9.67B
Income	222.40M
Sales	2.59B
Book/sh	268.30
Cash/sh	60.30
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	7450
IPO	Feb 27, 1980

P/E	44.72
Forward P/E	35.15
PEG	6.19
P/S	3.83
P/B	1.38
P/C	6.12
P/FCF	28.09
EV/EBITDA	21.83
EV/Sales	3.73
Quick Ratio	2.33
Current Ratio	3.14
Debt/Eq	0.19
LT Debt/Eq	0.13
Option/Short	Yes / Yes

EPS (ttm)	8.25
EPS next Y	10.50
EPS next Q	2.23
EPS this Y	-1.73%
EPS next Y	7.72%
EPS next 5Y	5.68%
EPS past 3/5Y	- -26.08%
Sales past 3/5Y	-2.68% 0.29%
EPS Y/Y TTM	-29.25%
Sales Y/Y TTM	1.37%
EPS Q/Q	18.67%
Sales Q/Q	-0.09%
Earnings	Aug 04 AMC
EPS/Sales Surpr.	49.92% 4.33%

Insider Own	33.28%
Insider Trans	-0.01%
Inst Own	72.27%
Inst Trans	-5.66%
ROA	2.17%
ROE	3.11%
ROIC	2.74%
Gross Margin	51.86%
Oper. Margin	9.08%
Profit Margin	8.59%
SMA20	-1.95%
SMA50	0.96%
SMA200	19.96%
Trades

Shs Outstand	21.68M
Shs Float	17.84M
Short Float	5.60%
Short Ratio	3.58
Short Interest	1.00M
52W High	396.23 -6.84%
52W Low	236.73 55.93%
Volatility	3.48% 2.81%
ATR (14)	11.08
RSI (14)	47.43
Beta	1.06
Rel Volume	0.00
Avg Volume	278.88K
Volume	0

Perf Week	-3.11%
Perf Month	-4.99%
Perf Quarter	25.07%
Perf Half Y	31.84%
Perf YTD	21.83%
Perf Year	25.46%
Perf 3Y	5.00%
Perf 5Y	-50.25%
Perf 10Y	125.35%
Recom	3.00
Target Price	352.50
Prev Close	369.14
Price	369.14
Change %	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
May-15-26	Resumed	RBC Capital Mkts	Outperform	$320
Apr-07-26	Downgrade	Citigroup	Buy → Neutral	$300
Oct-01-24	Upgrade	Citigroup	Neutral → Buy	$350 → $400
Aug-28-24	Initiated	Wells Fargo	Equal Weight	$340
Jun-03-24	Resumed	Jefferies	Hold	$315
Apr-03-24	Downgrade	Citigroup	Buy → Neutral	$400 → $365
Dec-07-23	Initiated	UBS	Buy	$395
Jun-16-23	Initiated	Wells Fargo	Overweight	$550
Dec-07-22	Initiated	RBC Capital Mkts	Outperform	$565
Aug-25-22	Initiated	Credit Suisse	Outperform	$715
Jan-28-22	Reiterated	Citigroup	Buy	$915 → $750
Jan-08-20	Initiated	Wells Fargo	Overweight	$430
Jan-07-20	Initiated	Citigroup	Buy	$450
Oct-17-18	Initiated	Goldman	Buy	$350
Sep-20-18	Initiated	Morgan Stanley	Equal-Weight	$335
Feb-16-18	Downgrade	CL King	Buy → Neutral
Jul-13-17	Initiated	Wells Fargo	Outperform
Jun-28-17	Upgrade	Deutsche Bank	Hold → Buy	$220 → $255
Jan-18-17	Initiated	Deutsche Bank	Hold	$195
Oct-13-16	Initiated	CL King	Buy

Show Previous Ratings

Sep-24-26 06:34AM	Biodesix Advances MRD Monitoring Programs With Bio-Rad and Thermo Fisher (InvestorsHub)
Sep-16-26 09:00AM	Bio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum (Business Wire)
Sep-08-26 03:37PM	ILMN Stock Keeps Climbing. Should You Climb On? (Trefis)
Aug-31-26 09:00AM	Bio-Rad to Participate in Fireside Chat During Wells Fargos 21st Annual Healthcare Conference (Business Wire)
Aug-05-26 08:30AM	Bio-Rad Laboratories, Inc. Q2 2026 Earnings Call Summary (Moby)
01:02AM	Loading…
01:02AM	Bio-Rad Laboratories Inc (BIO) (Q2 2026) Earnings Call Highlights: Digital PCR Surges 20%+ as ... (GuruFocus.com)
Aug-04-26 10:57PM	Bio-Rad: Q2 Earnings Snapshot (Associated Press)
04:15PM	Bio-Rad Reports Second-Quarter 2026 Financial Results (Business Wire)
Jul-30-26 02:29PM	Avantor Stock Surged Because One Segment Stopped Shrinking (Trefis)
Jul-23-26 09:00AM	Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026 (Business Wire)
May-22-26 01:25PM	Elliott Targets Bio-Rad After 70% Stock Collapse (GuruFocus.com)
May-18-26 07:57AM	LiveRamp's stock soars after France's Publicis Groupe said it would acquire the company in $2.2 billion deal (MarketWatch) +13.85%
May-17-26 08:03PM	Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad (The Wall Street Journal)
May-08-26 09:00AM	Bio-Rad to Participate in Upcoming Investor Conferences (Business Wire)
May-01-26 08:30AM	Bio-Rad Laboratories, Inc. Q1 2026 Earnings Call Summary (Moby) -8.41%
03:19AM	Loading…
03:19AM	Bio-Rad Laboratories Inc (BIO) Q1 2026 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Apr-30-26 05:06PM	Bio-Rad: Q1 Earnings Snapshot (Associated Press)
04:15PM	Bio-Rad Reports First-Quarter 2026 Financial Results (Business Wire)
Apr-16-26 04:15PM	Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026 (Business Wire)
Feb-26-26 07:29PM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research)
Feb-20-26 09:15AM	International Markets and Bio-Rad (BIO): A Deep Dive for Investors (Zacks)
Feb-19-26 02:42PM	Bio-Rad Laboratories, Inc. (BIO) Achieves Modest Revenue Growth and Robust Free Cash Flow Growth (Insider Monkey)
08:33AM	Bio-Rad's Q4 Earnings Miss Estimates, Revenues Surpass, Stock Down (Zacks)
Feb-17-26 10:14AM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research)
Feb-13-26 04:34PM	Stocks Settle Slightly Higher as Bond Yields Fall (Barchart) -12.26%
10:02AM	Stocks Edge Lower as AI Fears Linger (Barchart)
08:30AM	Bio-Rad Laboratories, Inc. Q4 2025 Earnings Call Summary (Moby)
12:02AM	Bio-Rad Laboratories Inc (BIO) Q4 2025 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Feb-12-26 10:10PM	Bio-Rad Laboratories Q4 Earnings Call Highlights (MarketBeat)
05:59PM	Bio-Rad: Q4 Earnings Snapshot (Associated Press Finance)
05:35PM	Loading…
05:35PM	Bio-Rad Laboratories (BIO) Q4 Earnings Miss Estimates (Zacks)
04:15PM	Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results (Business Wire)
Jan-29-26 08:30AM	Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026 (Business Wire)
Jan-21-26 08:11AM	Qiagen Explores Possible Sale After New Buyer Talks: Report (Benzinga)
08:01AM	Here's Why You Should Hold Bio-Rad Stock in Your Portfolio Now (Zacks)
Oct-30-25 05:17PM	Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday (Motley Fool)
11:45AM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research)
09:04AM	Bio-Rad's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Falls (Zacks)
Oct-29-25 05:55PM	Bio-Rad Laboratories (BIO) Q3 Earnings Miss Estimates (Zacks)
05:23PM	Bio-Rad: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Bio-Rad Reports Third-Quarter 2025 Financial Results (Business Wire)
Oct-28-25 09:25AM	What to Expect from Bio-Rad Laboratories Inc (BIO) Q3 2025 Earnings (GuruFocus.com)
Oct-24-25 01:30PM	Bio-Rad (BIO) Surged as the Earnings Exceeded Expectations (Insider Monkey)
Oct-23-25 11:44AM	What Makes Bio-Rad Laboratories (BIO) an Investment Bet? (Insider Monkey)
10:00AM	Envista (NVST) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-22-25 10:00AM	Bio-Rad Laboratories (BIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-16-25 05:30PM	Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025 (Business Wire)
Oct-08-25 06:12AM	Aurora Cannabis (ACB) Soars 6.2%: Is Further Upside Left in the Stock? (Zacks)
Oct-01-25 07:52PM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research) +6.26%
Sep-18-25 10:39AM	Bio-Rad Laboratories, Inc. (BIO) Launches New Instruments, Boosts Molecular Testing Reach (Insider Monkey)
Sep-02-25 08:23AM	Is Bio-Rad Laboratories (BIO) Entering a Period of More Sustained Recovery? (Insider Monkey)
Sep-01-25 10:17AM	Is it Apt to Hold Bio-Rad Stock in Your Portfolio Now? (Zacks)
Aug-22-25 07:47PM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research) +6.59%
Aug-13-25 08:41AM	Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge (GlobeNewswire)
Aug-12-25 04:49AM	STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMeriuex, Hologic, Bio-Rad Laboratories (GlobeNewswire)
Aug-02-25 07:48AM	Bio-Rad (BIO) Beats Q2 Earnings Estimates, Boosts Outlook With Strong Revenue Growth (Insider Monkey)
Aug-01-25 12:31PM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research) +17.63%
09:00AM	Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025 (Business Wire)
03:39AM	Bio-Rad Laboratories Inc (BIO) Q2 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com)
Jul-31-25 05:28PM	Bio-Rad: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	Bio-Rad Reports Second-Quarter 2025 Financial Results (Business Wire)
Jul-30-25 09:28AM	Bio-Rad Laboratories Inc (BIO) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
05:08AM	Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic (GlobeNewswire)
Jul-29-25 10:00AM	ADLM announces 2025 Top Corporate Supporter Award recipients and thanks them for their vital backing (PR Newswire)
04:31AM	North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers (GlobeNewswire)
04:02AM	Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche (GlobeNewswire)
Jul-28-25 04:15PM	Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations (Business Wire)
Jul-25-25 10:44PM	Bio-Rad Laboratories, Inc. (BIO) Launches New Digital PCR Systems in 2025 (Insider Monkey)
Jul-24-25 10:00AM	Earnings Preview: Bio-Rad Laboratories (BIO) Q2 Earnings Expected to Decline (Zacks)
Jul-17-25 04:15PM	Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025 (Business Wire)
Jul-16-25 04:07AM	Saudi Arabia In-Vitro Diagnostics Market Report 2025-2030 Featuring Abbott, BD, Bio-Rad Laboratories, Biomerieux, Danaher, Nihon Kohden, Roche, Siemens Healthineers, Sysmex, Thermo Fischer Scientific (GlobeNewswire)
Jul-14-25 08:07AM	Bio-Rad Stock Climbs Following the Launch of Four ddPCR Platforms (Zacks)
Jul-11-25 04:02AM	Ultrasensitive Molecular Amplification Market Research 2025-2035 \| Demand Surges for Early Detection, Molecular Amplification Techniques Lead the Way (GlobeNewswire)
Jul-10-25 05:19AM	New Strong Sell Stocks for July 10th (Zacks)
Jul-07-25 09:00AM	Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout (Business Wire)
Jun-16-25 08:30AM	Hologic's Margin Stability Amid Tariffs: What's Behind the Confidence? (Zacks)
May-29-25 04:30PM	Bio-Rads Management to Host Investor Meetings During Jefferies Global Healthcare Conference (Business Wire)
May-13-25 09:16AM	Investing in Bio-Rad (BIO)? Don't Miss Assessing Its International Revenue Trends (Zacks)
May-12-25 04:30PM	Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference (Business Wire) +7.54%
May-03-25 08:45AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
May-02-25 06:48PM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research)
07:58AM	BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket (Zacks)
May-01-25 10:35PM	Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:40PM	Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates (Zacks)
04:15PM	Bio-Rad Reports First-Quarter 2025 Financial Results (Business Wire)
Apr-29-25 12:59PM	Bio-Rad Laboratories, Inc. (BIO): Among Billionaire Mason Hawkins' Small-Cap Stocks with Huge Upside Potential (Insider Monkey)
Apr-24-25 10:35AM	Ariel Appreciation Fund Q1 2025 Commentary (Seeking Alpha)
10:25AM	Ariel Focus Fund Q1 2025 Commentary (Seeking Alpha)
10:01AM	Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-23-25 06:00AM	Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types (GlobeNewswire)
Apr-22-25 08:09AM	Does Bio-Rad Laboratories (BIO) Offer a Solid Financial Profile? (Insider Monkey)
Apr-21-25 08:08AM	Should You be Optimistic on Bio-Rad Laboratories's (BIO) Outlook? (Insider Monkey)
Apr-15-25 09:50PM	Parnassus Value Select ETF Q1 2025 Commentary (Seeking Alpha)
04:15PM	Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 (Business Wire)
Apr-13-25 12:48PM	Longleaf Partners Global Fund Q1 2025 Commentary (Seeking Alpha)
09:51AM	Longleaf Partners Fund Q1 2025 Commentary (Seeking Alpha)
Apr-10-25 01:29PM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research) -6.77%
Apr-04-25 08:28PM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research)
Apr-03-25 09:00AM	Should You Continue to Hold Bio-Rad Stock in Your Portfolio? (Zacks)
Mar-31-25 10:00AM	Bio-Techne Opens New Customer Experience Centre in Germany (Zacks)

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. The Life Science segment includes development, manufacturing, and marketing of instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials. The Clinical Diagnostics segment focuses on designing, manufacturing, marketing, and support of diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Chairman & CEOMr. Norman D. Schwartz

President & COOMr. Jonathan P. DiVincenzo

Executive VP & CFOMr. Roop K. Lakkaraju CPA

Executive VP & President of Life Science GroupMr. James J. Barry

Executive Vice President of Global Commercial OperationsMr. Rajat Mehta

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Allison Schwartz	Director	Sep 06 '26	Option Exercise	0.00	92	0	1,768	Sep 09 06:47 PM
Allison Schwartz	Director	Sep 05 '26	Option Exercise	0.00	228	0	1,758	Sep 09 06:47 PM
BARRY JAMES	EVP, President, LSG	Sep 06 '26	Option Exercise	0.00	1,056	0	2,495	Sep 09 06:46 PM
BARRY JAMES	EVP, President, LSG	Sep 05 '26	Option Exercise	0.00	1,027	0	1,808	Sep 09 06:46 PM
EVRAN SEDAT	EVP, Global Supply Chain	Sep 06 '26	Option Exercise	0.00	864	0	3,880	Sep 09 06:46 PM
EVRAN SEDAT	EVP, Global Supply Chain	Sep 05 '26	Option Exercise	0.00	1,027	0	3,345	Sep 09 06:46 PM
ENGELHARDT EVA ANETTE	EVP, President, CDG	Sep 06 '26	Option Exercise	0.00	1,152	0	2,313	Sep 09 06:45 PM
ENGELHARDT EVA ANETTE	EVP, President, CDG	Sep 05 '26	Option Exercise	0.00	1,027	0	1,530	Sep 09 06:45 PM
DiVincenzo Jonathan P.	President & COO	Sep 05 '26	Option Exercise	0.00	1,712	0	2,631	Sep 09 06:45 PM
ENLOE COURTNEY C	EVP, General Counsel & Sec	Sep 06 '26	Option Exercise	0.00	768	0	1,957	Sep 09 06:45 PM
ENLOE COURTNEY C	EVP, General Counsel & Sec	Sep 05 '26	Option Exercise	0.00	685	0	1,435	Sep 09 06:45 PM
Mehta Rajat	EVP, GBL Commercial Operations	Sep 05 '26	Option Exercise	0.00	1,826	0	1,736	Sep 09 06:44 PM
Lakkaraju Roop Kalyan	EVP, Chief Financial Officer	Sep 06 '26	Option Exercise	0.00	1,536	0	4,933	Sep 09 06:42 PM
Lakkaraju Roop Kalyan	EVP, Chief Financial Officer	Sep 05 '26	Option Exercise	0.00	1,370	0	3,956	Sep 09 06:42 PM
SCHWARTZ NORMAN D	Chairman & CEO	Sep 06 '26	Option Exercise	0.00	3,455	0	450,873	Sep 09 06:42 PM
SCHWARTZ NORMAN D	Chairman & CEO	Sep 05 '26	Option Exercise	0.00	4,109	0	450,294	Sep 09 06:42 PM
BARRY JAMES	EVP, President, LSG	Sep 01 '26	Option Exercise	0.00	425	0	935	Sep 03 05:41 PM
Allison Schwartz	Director	Sep 01 '26	Option Exercise	0.00	117	0	1,573	Sep 03 05:38 PM
SCHWARTZ NORMAN D	Chairman & CEO	Sep 01 '26	Option Exercise	0.00	5,087	0	448,521	Sep 03 05:35 PM
ENGELHARDT EVA ANETTE	EVP, President, CDG	Jul 25 '26	Option Exercise	0.00	246	0	592	Jul 28 03:05 PM
Alles Institute for Medical Re	Director	May 28 '26	Proposed Sale	313.28	700	219,296		May 28 03:04 PM
ENGELHARDT EVA ANETTE	EVP, President, CDG	May 11 '26	Sale	246.54	550	135,597	346	May 13 03:38 PM
EVA ENGELHARDT	Officer	May 11 '26	Proposed Sale	246.54	550	135,597		May 11 05:03 PM
Lakkaraju Roop Kalyan	EVP, Chief Financial Officer	Apr 24 '26	Option Exercise	0.00	1,078	0	2,984	Apr 28 12:21 PM
ENLOE COURTNEY C	EVP, General Counsel & Sec	Apr 24 '26	Option Exercise	0.00	186	0	827	Apr 28 12:20 PM
Hinckley Greg K	Director	Apr 21 '26	Option Exercise	0.00	407	0	1,215	Apr 23 03:26 PM
PEI MELINDA LITHERLAND	Director	Apr 21 '26	Option Exercise	0.00	407	0	715	Apr 23 03:25 PM
EDWARDS JEFFREY L	Director	Apr 21 '26	Option Exercise	0.00	407	0	715	Apr 23 03:24 PM
PINKSTON ARNOLD A	Director	Apr 21 '26	Option Exercise	0.00	407	0	715	Apr 23 03:23 PM
MICHAEL W CROWLEY	Officer	Dec 02 '25	Proposed Sale	319.56	776	247,979		Dec 02 06:27 PM
Alles Institute for Medical Re	Director	Nov 18 '25	Proposed Sale	301.04	760	228,793		Nov 18 01:03 PM
BARRY JAMES	EVP, President, LSG	Nov 06 '25	Sale	306.18	700	214,289	510	Nov 10 04:15 PM
JAMES BARRY	Officer	Nov 06 '25	Proposed Sale	306.18	701	214,633		Nov 06 04:24 PM
DiVincenzo Jonathan P.	President & COO	Oct 24 '25	Option Exercise	0.00	1,869	0	1,869	Oct 28 12:29 PM
EVRAN SEDAT	EVP, Global Supply Chain	Oct 20 '25	Option Exercise	0.00	1,044	0	2,568	Oct 21 04:42 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BIO

Bio-Rad Laboratories Inc

Upgrade your Finviz experience